Assessment of suitability of thrombolysis in middle cerebral artery infarction: A proof of concept study of a stereologically-based technique

Cerebrovascular Diseases

Volumn 24, Issue 4, 2007, Pages 321-327

  Phan, Thanh G ^a,b,e   Donnan, Geoffrey A ^a,e   Koga, Masatoshi ^a,e   Mitchell, L Anne ^c,d   Molan, Maurice ^c   Fitt, Gregory ^c   Chong, Winston ^f   Holt, Michael ^f   Reutens, David C ^e  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b Department of Medicine ^*  (Australia)

^c AUSTIN HEALTH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

Author keywords

Likelihood ratio; Middle cerebral artery; Stroke; Thrombolysis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CEREBRAL ARTERY DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGING; MALE; PRIORITY JOURNAL; RADIOLOGIST; SENSITIVITY AND SPECIFICITY; STEREOMETRY; STROKE;

AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; OBSERVER VARIATION; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34748902926     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106977     Document Type: Article

References (23)

1. Bonita R: Epidemiology of stroke. Lancet 1992;339:342-344.
2. Mar J, Begiristain JM, Arrazola A: Cost-effectiveness analysis of thrombolytic treatment for stroke. Cerebrovasc Dis 2005;20:193-200.
3. Hack W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K, et al: European Stroke Initiative Recommendations for Stroke Management - update 2003. Cerebrovasc Dis 2003;16:311-337.
4. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, et al: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083.
5. Boode B, Welzen V, Franke C, van Oostenbrugge R: Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided. Cerebrovasc Dis 2006;23:294-298.
6. Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, et al: Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330-1335.
7. von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C, et al: Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327-333.
8. Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, et al: Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999;30:2280-2284.
9. Larrue V, von Kummer R, del Zoppo G, Bluhmki E: Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997;28:957-960.
10. Kalafut MA, Schriger DL, Saver JL, Starkman S: Detection of early CT signs of >1/3 middle cerebral artery infarctions: interrater reliability and sensitivity of CT interpretation by physicians involved in acute stroke care. Stroke 2000;31:1667-1671.
11. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, et al: Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002;105:1679-1685.
12. Barber PA, Demchuk AM, Zhang J, Buchan AM: Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-1674.
13. Mak HK, Yau KK, Khong PL, Ching AS, Cheng PW, Au-Yeung PK, et al: Hypodensity of >1/3 middle cerebral artery territory versus Alberta Stroke Programme Early CT Score (ASPECTS): comparison of two methods of quantitative evaluation of early CT changes in hyperacute ischemic stroke in the community setting. Stroke 2003;34:1194-1196.
14. Marks MP, Holmgren EB, Fox AJ, Patel S, von Kummer R, Froehlich J: Evaluation of early computed tomographic findings in acute ischemic stroke. Stroke 1999;30:389-392.
15. Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, et al: Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 2001;22:1534-1542.
16. Phan TG, Donnan GA, Koga M, Mitchell LA, Molan M, Fitt G, et al: The ASPECTS template is weighted in favor of the striatocapsular region. Neuroimage 2006;31:477-481.
17. Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR: Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 2005;36:2110-2115.
18. Lyden PD, Zweifler R, Mahdavi Z, Lonzo L: A rapid, reliable, and valid method for measuring infarct and brain compartment volumes from computed tomographic scans. Stroke 1994;25:2421-2428.
19. Phan TG, Donnan GA, Wright PM, Reutens DC: A digital map of middle cerebral artery infarcts associated with middle cerebral artery trunk and branch occlusion. Stroke 2005;36:986-991.
20. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
21. Biggerstaff BJ: Comparing diagnostic tests: a simple graphic using likelihood ratios. Stat Med 2000;19:649-663.
22. Johnson NP: Advantages to transforming the receiver operating characteristic (ROC) curve into likelihood ratio coordinates. Stat Med 2004;23:2257-2266.
23. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, et al: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.